Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.27153
Abstract: Completion lymph node dissection (CLND) was the standard treatment for patients with melanoma with positive sentinel lymph nodes (SLN) until 2017 when data from the DeCOG‐SLT and MLST‐2 randomized trials challenged the survival benefit of… read more here.
Keywords: dissection clnd; completion lymph; node dissection; lymph node ... See more keywords
Use of Completion Lymph Node Dissection for Sentinel Lymph Node Positive Melanoma.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American College of Surgeons"
DOI: 10.1016/j.jamcollsurg.2019.12.010
Abstract: BACKGROUND For patients with sentinel node positive melanoma (SNPM), randomized trials, first reported in 2015, show no benefit for routine completion lymph node dissection (CLND) in selected patients. This study examines time trends in CLND… read more here.
Keywords: node dissection; node positive; clnd; completion lymph ... See more keywords
Evidence and implementation gaps in management of sentinel node-positive melanoma in the United States.
Sign Up to like & getrecommendations! Published in 2022 at "Surgery"
DOI: 10.1016/j.surg.2021.12.025
Abstract: BACKGROUND Melanoma clinical trials demonstrated that completion lymph node dissection is low value for most sentinel lymph node-positive patients. Contemporaneous trials of adjuvant systemic immunotherapy and BRAF/MEK targeted therapy showed improved recurrence-free survival in high-risk… read more here.
Keywords: lymph node; node dissection; completion lymph; lymph ... See more keywords